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Introduction
Neuroinflammation plays an important role in the pathological processes of neurodegenerative and neuropsychiatric disorders, including Parkinson's disease (PD) (Wang et al., 2014) . Microglia, as the resident macrophages of brain, are recognized as the major innate immune cells in the central nervous system, and are key cellular mediators of neuroinflammatory processes (Gendelman, 2002; Walker et al., 2014) . Like monocytes/macrophages, activated microglia produce and release proinflammatory cytokines and neurotoxic mediators after stimulation with lipopolysaccharide (LPS) or interferon (IFN)-c in vitro (Dong and Zhen, 2015; Rice et al., 2015) . Although inflammatory cytokines such as interleukin-6 (IL-6), interleukin-1 beta (IL-1b) and tumor necrosis factor alpha (TNF-a) are endogenous mechanisms in response to various inflammatory insults, they are also toxic to neurons (Streit et al., 2004) . In this regard, dopaminergic neurons are particularly vulnerable to proinflammatory toxic factors released by activated glial cells (Herrero et al., 2015) . In both experimental PD animals and PD patients, the large number of reactive microglia and increases in proinflammatory cytokines in the substantia nigra pars compacta (SNc) have been repeatedly demonstrated to be associated with the pathological process of the diseases (Exner et al., 2012) . Therefore, inhibition of the microglia-mediated inflammatory response has become a focal point in efforts to reduce tissue damage and ameliorate the neurodegenerative process.
Recent studies have indicated that glycolytic metabolism plays a critical role in inflammatory regulation (O'Neill and Hardie, 2013) . The M1 type of activated macrophages exhibits enhanced activation of the glycolysis and pentose phosphate pathway, whereas the M2 type undergoes a switch to enhanced oxidative phosphorylation (Krawczyk et al., 2010) . When stimulated with LPS or interferon-c (IFN-c), macrophages undergo aerobic
